LF
OGN icon

LifeSteps Financial’s Organon & Co OGN Stock Holding History

LifeSteps Financial’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$460 Buy
+34
New +$407 ﹤0.01% 760
2024
Q2 		– Sell
-34
Closed -$639 – 301
2024
Q1 		$639 Buy
+34
New +$583 ﹤0.01% 419

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

LifeSteps Financial's OGN Position: Q2 2026 in Review

LifeSteps Financial opened a new position in Organon & Co (OGN) in Q2 2026: 34 shares worth $460. The stake represents ﹤0.01% of the portfolio and ranks #760 among its holdings. This is a return to the name: LifeSteps Financial previously reported a position in OGN as recently as Q1 2024.

LifeSteps Financial first reported a position in OGN in Q1 2024 and has held it in 2 quarters since. The position peaked at $639 in Q1 2024. 634 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • LifeSteps Financial held 34 shares of Organon & Co worth $460 as of Q2 2026.
  • Organon & Co was a new LifeSteps Financial position in Q2 2026.
  • Organon & Co made up ﹤0.01% of LifeSteps Financial's portfolio in Q2 2026, its #760 holding.
  • LifeSteps Financial first reported a position in Organon & Co in Q1 2024 and has held it in 2 quarters since.
  • LifeSteps Financial's Organon & Co position peaked at $639 in Q1 2024.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on LifeSteps Financial's 13F filing for Q2 2026, filed 17 Jul 2026.